Project

Development of KRN 7000 analogues with an improvement selectivity profile

Code
3F003407
Duration
01 October 2007 → 30 September 2010
Funding
Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
Research disciplines
  • Natural sciences
    • Organic chemistry
  • Medical and health sciences
    • Biomarker discovery and evaluation
    • Drug discovery and development
    • Medicinal products
    • Pharmaceutics
    • Pharmacognosy and phytochemistry
    • Pharmacology
    • Pharmacotherapy
    • Toxicology and toxinology
    • Other pharmaceutical sciences
Keywords
NKT cells synthese KRN 7000
 
Project description

Synthesis of alfa-galactosylceramide (KRN 7000) analogues with potential induction of a polarised cytokine respons (Th1 or Th2) by NKT cells. The proposed modifications intend an improved bindingafffinity with the CD1d protein. This should result in a bias towards a Th1 respons.